Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 1,798 shares at $62.09 ($113K) on 2026-01-02, disclosed to the SEC on 2026-01-02.
Open-market sale of $113k CYTK by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.09 | 913 | $57K | 50.4% |
| 2 | $63.16 | 885 | $56K | 49.6% |
| Total | $62.62 avg | 1,798 | $113K | 100% |
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |